Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11707448 Combination therapies for the treatment of cancer

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Eisai
Eisai
0
Date Filed
November 17, 2021
0
Date of Patent
July 25, 2023
0
Patent Applicant
Eisai
Eisai
0
Patent Application Number
17528510
0
Patent Citations
‌
US Patent 8354509 Antibodies to human programmed death receptor PD-1
0
‌
US Patent 8383796 Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 8552154 Anti-PD-L1 antibodies and uses therefor
0
‌
US Patent 8617546 Anticancer agent comprising anti-PD-1 antibody or anti-PD-L1 antibody
0
‌
US Patent 8685394 Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
0
‌
US Patent 8686018 Pharmaceutical composition
0
‌
US Patent 8709417 Combination immunotherapy for the treatment of cancer
0
‌
US Patent 9000024 Pharmaceutical composition
0
‌
US Patent 8921391 Selective EP4 receptor antagonistic substance for treatment of cancer
0
‌
US Patent 7488802 Antibodies against PD-1
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11707448
0
Patent Primary Examiner
‌
Jeffrey S Lundgren
0
CPC Code
‌
A61K 39/00
0
‌
A61K 2039/505
0
‌
A61K 31/415
0
‌
C07K 16/2818
0
‌
C07K 16/2827
0
‌
A61K 2300/00
0
‌
A61K 31/7068
0

Find more entities like US Patent 11707448 Combination therapies for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo